Jase99, To expand on your post a little further. By the years end we will have results across a multiple range of cancers for over 100 patients treated with the OBD. Or close enough to OBD CF33 covering Vaxinia and Oncarlytics.
If the results keep improving as we are seeing from todays results, there will be ample evidence to have every BP CEO on the company phone.
Just add in the another Rare Disease/Orphan Indication which seems likely with “Cholangiocarcinoma ” being highlighted. BP love rare diseases.
In some ways it’s a really exciting twist in the story, that 2 rare diseases have popped up on the radar already at this early point in time. We could see a few more of these.
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals, page-79
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.001(1.92%) |
Mkt cap ! $374.8M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.3¢ | 5.0¢ | $983.7K | 19.10M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 492446 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 382941 | 3 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |